Study Finds 16:8 Intermittent Fasting Effective for Weight Loss Only
Intermittent fasting, particularly time-restricted eating (TRE), is gaining popularity as a dietary approach aimed at improving health. A new study published in the journal Nutrition & Diabetes has investigated how varying the duration of eating windows affects weight loss and cardiometabolic health markers. In TRE, individuals consume all their daily calories within a specified time frame, typically ranging from 8 to 12 hours, followed by a fasting period. This study pooled data from five prior TRE studies to assess the impact of different eating-window durations on weight loss and various health indicators.
The study involved 124 participants, with 95 assigned to TRE and 29 serving as a control group. Participants in the TRE groups followed different eating windows: 11 were assigned to an 8-hour window, 59 to a 10-hour window, and 25 to a 12-hour window. The control group maintained their usual eating habits or received brief nutritional counseling. The trials lasted between 3 to 6 months, during which participants tracked their food intake using a mobile app, submitting timestamped photos and descriptions of their meals.
Results showed that participants in the TRE groups reduced their daily eating windows by an average of 4 hours and lost approximately 4.8 pounds during the study. Notably, those in the 8-hour group lost about 3.7 pounds more than those in the 12-hour group, and significantly more than those in the control group. However, the analysis revealed no statistically significant weight loss difference between the 8- and 10-hour groups. The control group also experienced some weight loss, but it was not statistically significant.
When examining the relationship between eating window duration and health outcomes, researchers found no consistent improvements in markers such as fasting glucose, HDL or LDL cholesterol, and triglycerides. The only significant cardiometabolic finding was that participants in the 10-hour group experienced a greater reduction in systolic blood pressure compared to those in the 12-hour group.
The study does have limitations, including a lack of data on participants' calorie intake, a small sample size, and relatively short follow-up periods. Moreover, not all trials included in the analysis were randomized controlled trials, which may affect the robustness of the findings. Experts like Cheng-Han Chen, MD, and Mir Ali, MD, who were not involved in the study, noted that the small sample size and variability among trials could explain the limited cardiometabolic results. They emphasized the need for larger, longer-duration studies to better understand the potential health benefits of TRE beyond weight loss and to identify which populations may benefit most. They also advised individuals with certain health conditions to consult healthcare professionals before attempting TRE.




